Table of Contents

company-logo

MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.

MabCure Dividend Announcement

• MabCure does not currently offer dividends, we're keeping a close eye on its growth potential and financial developments.
• Stay tuned for updates on MabCure dividend policy and future announcements. In the meantime, explore other dividend-yielding opportunities on our website.

MabCure Dividend History

MabCure Dividend Yield

MabCure current trailing twelve-month (TTM) dividend yield is -%. Interested in purchasing MabCure stock? Use our calculator to estimate your expected dividend yield:

MabCure Financial Ratios

P/E ratio0.00
PEG ratio0.00
P/B ratio0.00
ROE-127.05%
Payout ratio0.00%
Current ratio0.17
Quick ratio0.16
Cash Ratio0.16

MabCure Dividend FAQ

Does MabCure stock pay dividends?
MabCure does not currently pay dividends to its shareholders.
Has MabCure ever paid a dividend?
No, MabCure has no a history of paying dividends to its shareholders. MabCure is not known for its dividend payments.
Why doesn't MabCure pay dividends?
There are several potential reasons why MabCure would choose not to pay dividends to their shareholders:

1. Growth opportunities: Companies, especially in fast-growing industries like technology, reinvest earnings into expansion, R&D, or acquisitions to fuel future growth and increase company value.

2. Tax implications: Not paying dividends can reduce the tax burden on shareholders, who may prefer to defer taxes until selling shares and realizing capital gains.

3. Investor preferences: Some investors prefer companies to reinvest profits for higher long-term returns, particularly those seeking capital appreciation over income.

4. Capital allocation priorities: Companies may allocate cash to pay down debt, fund share buybacks, or invest in projects with higher returns than dividends.

5. Market expectations: In certain sectors, like technology, reinvesting profits for growth and innovation is often prioritized over distributing dividends to shareholders.
Will MabCure ever pay a dividend?
The decision for a company to pay dividends depends on various factors including its financial performance, growth prospects, capital allocation priorities, and shareholder preferences. While MabCure has not paid dividends historically and has instead focused on reinvesting its earnings for growth, it's ultimately up to the company's management and board of directors to decide whether to initiate a dividend policy in the future.
Is MabCure a dividend aristocrat?
MabCure is not considered a Dividend Aristocrat. The term "Dividend Aristocrat" is typically used to describe a company in the S&P 500 index that has increased its dividend payouts for at least 25 consecutive years.
Is MabCure a dividend king?
MabCure is not classified as a "Dividend King". A Dividend King is a company that has managed to increase its dividend payouts for 50 consecutive years or more, which is an even more selective group than the Dividend Aristocrats.
Is MabCure a dividend stock?
No, MabCure is not considered a dividend stock. A dividend stock is a stock of a company that regularly pays out dividends to its shareholders.
How to buy MabCure stocks?
To buy MabCure you need a brokerage account. Open an account with a reputable brokerage firm that offers access to the stock market. Consider factors such as fees and account minimums.

Place an order: Use the brokerage's trading platform to place an order to buy MabCure stock.

Remember that buying stocks involves risk, and it's important to carefully consider your investment goals, risk tolerance, and conduct thorough research before making any investment decisions.